Omnio Rec-PLG
Recombinant plasminogen candidate for chronic wound healing
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
Omnio Rec-PLG is Omnio's recombinant plasminogen drug candidate intended to help clear damaged tissue, fight infection, and regenerate skin in hard-to-heal chronic wounds, starting with diabetic foot ulcers. The therapy is designed for subcutaneous administration and is progressing toward clinical studies.
- Website
- omnio.se
- Added via
- web
- Ownership
- unclaimed
Where to go
For people
- Homepageomnio.se
For agents
Nothing listed yet.